Churg-Strauss syndrome overview: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 9: Line 9:


==Classification==
==Classification==
Revised International Chapel Hill Consensus Conference 2012 on nomenclature of vasculitides, defines [[eosinophilic granulomatosis with polyangiitis]] (formerly known as Churg - Strauss syndrome) as an [[eosinophilic]], [[Inflammation|granulomatous inflammatory disease]] affecting most commonly the [[Respiratory tract|conducting pulmonary airways]], and leading to a [[necrosis]] of the small and/or medium sized vessels. [[Eosinophilic granulomatosis with polyangiitis]] is often synonymous with adult-onset [[asthma]]. According to revised CHCC 2012, [[eosinophilic granulomatosis with polyangiitis]] is considered as a variant of the [[Anti-neutrophil cytoplasmic antibody|ANCA]] - associated vasculitis.


==Pathophysiology==
==Pathophysiology==

Revision as of 16:04, 2 April 2018

Churg-Strauss syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Churg-Strauss syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Churg-Strauss syndrome overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Churg-Strauss syndrome overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Churg-Strauss syndrome overview

CDC on Churg-Strauss syndrome overview

Churg-Strauss syndrome overview in the news

Blogs on Churg-Strauss syndrome overview

Directions to Hospitals Treating Churg-Strauss syndrome

Risk calculators and risk factors for Churg-Strauss syndrome overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Churg-Strauss syndrome is a medium and small vessel autoimmune vasculitis, leading to necrosis. It involves mainly the blood vessels of the lungs (it begins as a severe type of asthma), gastrointestinal system, and peripheral nerves, but also affects the heart, skin and kidneys. It is a rare disease that is non-heritable, non-transmissable and often mis-diagnosed.

Historical Perspective

Classification

Revised International Chapel Hill Consensus Conference 2012 on nomenclature of vasculitides, defines eosinophilic granulomatosis with polyangiitis (formerly known as Churg - Strauss syndrome) as an eosinophilicgranulomatous inflammatory disease affecting most commonly the conducting pulmonary airways, and leading to a necrosis of the small and/or medium sized vessels. Eosinophilic granulomatosis with polyangiitis is often synonymous with adult-onset asthma. According to revised CHCC 2012, eosinophilic granulomatosis with polyangiitis is considered as a variant of the ANCA - associated vasculitis.

Pathophysiology

Eosinophilic granulomatosis with polyangiitis is a medium and small vessel vasculitis, leading to necrosis. The pathogenesis of Eosinophilic granulomatosis with polyangiitis is not fully understood. Eosinophilic granulomatosis with polyangiitis occurs as a result of a complex interaction involving genetic and environmental factors that lead to an inflammatory response involving eosinophils, lymphocytes. Autoimmunity has an evident role in the presence of ANCA, hypergammaglobulinemia, elevated levels of immunoglobulin E, and rheumatic factor in the pathogenesis. HLA-DRB4 is correlated with increased risk of development of vascular manifestations of the churg-strauss syndrome. On microscopic pathology, eosinophilic infiltration, necrotizing granulomas vasculitis and necrosis of small and medium-sized arteries can be seen.

Causes

Differentiating Churg-Strauss syndrome from Other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT Scan

Echocardiography or Ultrasound

Other Imaging Findings

Treatment

Medical Therapy

Surgery

Prevention

References

Template:WH Template:WS